Stock ALSE ALSERES PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Alseres Pharmaceuticals, Inc.

Equities

ALSE

US0211522026

Market Closed - OTC Markets
Other stock markets
 14:06:50 2023-10-18 EDT 		5-day change 1st Jan Change
0.005 USD -50.00% Intraday chart for Alseres Pharmaceuticals, Inc. -.--% -.--%
2015 Alseres Pharmaceuticals, Inc. cancelled the acquisition of E-IACFT Injection from Navidea Biopharmaceuticals, Inc. CI
2015 Alseres Pharmaceuticals, Inc. will Change its Ticker to ALSE from ALSED CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alseres Pharmaceuticals, Inc. cancelled the acquisition of E-IACFT Injection from Navidea Biopharmaceuticals, Inc.
CI
Alseres Pharmaceuticals, Inc. will Change its Ticker to ALSE from ALSED
CI
Alseres Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt
CI
Alseres Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt
CI
Alseres Pharmaceuticals, Inc. Licenses Altropane Rights to Navidea Biopharmaceuticals
CI
Alseres Pharmaceuticals, Inc. entered into an agreement to acquire E-IACFT Injection from Navidea Biopharmaceuticals, Inc for $3.4 million.
CI
Alseres Pharmaceuticals, Inc. Taken Out Licensing Agreement with Alseres Pharmaceuticals, Inc
CI
Alseres Pharmaceuticals, Inc. Reports License of Altropane(R) Worldwide Rights to Navidea Biopharmaceuticals, Inc
CI
Alseres Pharmaceuticals, Inc. announced that it has received $34.4 million in funding from Highbridge Capital Management, LLC, Ingalls & Snyder LLC, and other investors.
CI
Navidea Biopharmaceuticals to Continue its Diligence Through the End of July 2012 with Alseres Pharmaceuticals, Inc. to License E-IAFCT Injection
CI
Alseres Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt
CI
Navidea Biopharmaceuticals, Inc. Signs Option Agreement with Alseres Pharmaceuticals, Inc., to License Altropane
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALSE Stock
  4. News Alseres Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW